CATALYST BIOSCIENCES INC's ticker is CBIO and the CUSIP is 14888D208. A total of 82 filers reported holding CATALYST BIOSCIENCES INC in Q4 2020. The put-call ratio across all filers is 0.04 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $16 | +33.3% | 34,165 | 0.0% | 0.01% | +33.3% |
| Q2 2023 | $12 | +71.4% | 34,165 | 0.0% | 0.01% | +80.0% |
| Q1 2023 | $7 | -61.1% | 34,165 | 0.0% | 0.01% | -66.7% |
| Q4 2022 | $18 | -99.7% | 34,165 | +149.2% | 0.02% | +150.0% |
| Q3 2022 | $7,000 | -70.8% | 13,712 | 0.0% | 0.01% | -68.4% |
| Q2 2022 | $24,000 | +166.7% | 13,712 | 0.0% | 0.02% | +216.7% |
| Q1 2022 | $9,000 | -25.0% | 13,712 | 0.0% | 0.01% | -25.0% |
| Q4 2021 | $12,000 | -78.6% | 13,712 | 0.0% | 0.01% | -80.0% |
| Q3 2021 | $56,000 | -5.1% | 13,712 | 0.0% | 0.04% | 0.0% |
| Q2 2021 | $59,000 | -14.5% | 13,712 | 0.0% | 0.04% | -18.4% |
| Q1 2021 | $69,000 | -20.7% | 13,712 | 0.0% | 0.05% | -22.2% |
| Q4 2020 | $87,000 | +47.5% | 13,712 | 0.0% | 0.06% | +28.6% |
| Q3 2020 | $59,000 | -26.2% | 13,712 | 0.0% | 0.05% | -30.0% |
| Q2 2020 | $80,000 | +35.6% | 13,712 | 0.0% | 0.07% | +27.3% |
| Q1 2020 | $59,000 | – | 13,712 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 66,951 | $13,859 | 0.01% |
| Colorado Capital Management, Inc. | 34,165 | $7 | 0.01% |
| Nantahala Capital Management | 160,430 | $33,209 | 0.00% |
| Kynam Capital Management, LP | 89,886 | $18,606 | 0.00% |
| Keebeck Wealth Management, LLC | 20,000 | $4,140 | 0.00% |
| MORGAN STANLEY | 38,404 | $7,950 | 0.00% |
| ACADIAN ASSET MANAGEMENT LLC | 259,467 | $52 | 0.00% |
| BlackRock Inc. | 169,904 | $35,170 | 0.00% |
| Bank of New York Mellon Corp | 200,638 | $41,532 | 0.00% |
| Citadel Advisors | 5,700 | $1,180 | 0.00% |